Search for: "CENTOCOR RESEARCH "
Results 21 - 31
of 31
Sort by Relevance
|
Sort by Date
11 Mar 2010, 12:23 pm
The doctor provided explicit, uncontroverted testimony that, even when provided with the most current research and FDA mandated warnings, he still would have proscribed Paxil for [the decedent’s] depression. [read post]
6 Jan 2010, 3:32 am
’ (The SPC Blog) India: Reviewing the Indian Patent Regime after 5 years of the introduction of the pharmaceutical product patent regime (Spicy IP) UK: Department of Health proposing generic prescription drugs option (GenericsWeb) US: 7th Circuit: Enforcing contracts between joint owners: Wisconsin Alumni Research Foundation (WARF) v. [read post]
1 Oct 2009, 2:14 am
We've done so many posts on removal - for you non-lawyers that means moving cases that were originally filed in state court into federal court - that even we have a hard time keeping track. [read post]
25 Sep 2009, 1:30 pm
., director, Office of Drug Evaluation III, in the FDA's Center for Drug Evaluation and Research. [read post]
9 Sep 2009, 7:14 am
– Dispute between Wyeth and Dexel (The IP Factor) EpiPen (Epinephrine) – US: King Pharmaceuticals, Meridian Medical Technology file patent infringement suit against Teva following Para IV certification (Patent Docs) Seroxat (Paroxetine) – Israel: not even sublime, just ridiculous – Israel PTO decision in Unipharm v SmithKline Beecham (America-Israel Patent Law) Stelara (Ustekinumab, anti-IL-12 antibody) – Centocor seeks review of BPAI… [read post]
26 Aug 2009, 6:12 am
(Korea IP Law Blog) US: Senate Agriculture/FDA Appropriations Bill amendment seeks to streamline development and regulation of products for rare and neglected diseases (FDA Law Blog) US: Professor Grabowski’s economic analysis of data exclusivity for follow-on biologic drugs (Patent Docs) US: Follow-on biologics news briefs: President Obama wants to speed up introduction of generic drugs; biosimilars pose ‘limited threat’; Amgen CEO says biologic manufacturers will… [read post]
19 Aug 2009, 5:41 am
HIV activists call for people’s property rights (Afro-IP) Innovation, IP and medical services (IP finance) Investors saw biotech rebound coming (Patent Docs) Seeded players – Corporate control in agricultural research (Patenting Lives) EU: Intellectual Property Institute initiative on paediatric inconsistencies links patent offices (The SPC Blog) EU: Questions about the codified Regulation No 469/2009 (The SPC Blog) India: Government of India accepts conclusions of… [read post]
8 Jul 2009, 7:04 am
(Spicy IP) India: Novartis patent rejection by the IPAB: Accessing the decision (Spicy IP) (IAM) India: Likely corruption in the Indian health care sector – Public interest litigation over government shutdown of vaccine production plants to enter contracts with private sector (IP Osgoode) Kenya: Manufacturers, public heath interests clash over anti-counterfeit law; AIDS patients to bring Constitutional challenge (Intellectual Property Watch) (Afro-IP) (Intellectual Property Watch) Spain:… [read post]
4 Jul 2009, 12:56 am
Abbott already took a beating from J&J in the Humira area over patents originating at New York University exclusively licensed to Centocor Ortho Biotech. [read post]
16 Apr 2009, 1:00 pm
This educational program is being provided by an educational grant from Centocor, Inc., with no-cost to attendees. [read post]
11 Dec 2006, 5:13 pm
"Centocor further contended that "the simple term PROGRAMMED PROTEIN does not aptly describe these complicated and sophisticated medical research services. [read post]
